Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
about
Hydroxychloroquine-related retinal toxicityA highlight from the LUPUS 2014 meeting: eight great ideasClinical applications of fundus autofluorescence in retinal diseaseThe impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.Extrapulmonary manifestations of sarcoidosis.Chloroquine cardiomyopathy - a review of the literature.Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.Humphrey visual field findings in hydroxychloroquine toxicityScotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathyA possible early sign of hydroxychloroquine macular toxicity.Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients.Scotoma analysis of 10-2 visual field testing with a red target in screening for hydroxychloroquine retinopathy.Hydroxychloroquine retinopathy: A review of imagingA case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment: a review of the literature on the use of hydroxychloroquine in renal impairment.Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquineEffect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography.Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients.Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study.Hydroxychloroquine: from malaria to autoimmunity.Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.The role of antimalarial agents in the treatment of SLE and lupus nephritis.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.Hydrochloroquine retinopathy: characteristic presentation with review of screening.Current immunotherapy in rheumatoid arthritis.A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity.Research progress of hydroxychloroquine and autophagy inhibitors on cancer.Hydroxychloroquine retinopathy.Retinal Findings on OCT in Systemic Conditions.Decisional support to prevent adverse drug reactions of long latency: pilot randomized controlled intervention for glucocorticoid-induced diabetes.Decreased Perifoveal Sensitivity Detected by Microperimetry in Patients Using Hydroxychloroquine and without Visual Field and Fundoscopic Anomalies.Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy.A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
P2860
Q26782822-B3D96B66-F25B-4136-9D61-71C10BFCC08EQ26823803-2A461966-1D03-4C02-8D20-B3C449ED8423Q28075181-F7DC051C-820F-40DA-B8E1-EE97F57A7FFEQ33976159-B5DA836D-2E3C-4E98-AA69-6E7710F613CEQ34005507-6F2847DC-F156-4868-ACC0-0FA7CA06E52DQ34315879-5C54E5F9-D918-403F-891E-A2BAC24CF8C4Q34340121-D5241D0B-60AB-447F-968D-2CB6149EC23BQ34342236-2A2A032E-F184-4CC3-9760-8B5257555178Q34446781-E5021123-78F3-411F-8337-87CF02C38796Q34520106-ED476622-9BA2-46B6-AC04-ADCA8FB6A7C8Q35456519-1DF81B32-A7BD-4198-BF77-D18969584A58Q35603566-C1CBA60E-5FBF-4FFA-BC57-0B885796DA7CQ35679381-EA04BC83-49B3-4D52-925B-BED5D741348CQ35899646-1ECF731E-0D17-4073-8709-CD6E6B16F4A0Q35957874-BD6DB8B3-F629-4008-894B-F6EBA030FDFFQ35994318-F4A12B62-6EE2-4846-B7FF-C35CF0A3C0D0Q36298100-E6E3B529-4F29-4CA8-9834-E1DFF90B1CADQ36470464-C4571A26-B31D-4516-8057-B3866D4D61B9Q37023500-44D1E135-C8DB-4B56-B11C-5F8BF9901698Q37253124-75ADE6DA-3FDD-4316-BF9C-BD29EF192998Q37398000-6441AE9D-33F3-47D2-ACA1-D376CDFDD338Q37622345-D25FA729-6AE5-4286-9204-AEB4D7E39B5FQ37695455-7A228D45-67B7-4BBA-9EE9-AA04EA8996F0Q37827403-309BD908-3EEC-48B4-B0AC-EED043BC52EFQ37854742-3FA16399-65C7-46CD-8658-E989069C5414Q37947108-36F9255A-FA21-426E-A5E0-DF101489FF56Q38029146-3F7B6769-8D38-4430-A9E8-BF220E331520Q38091637-F5B551AE-AB09-425E-88A8-A9071C13F6C7Q38133655-4AA78B6E-3F96-4484-9AE8-BD62A3D1B09FQ38352048-11F408C3-BC28-4983-9989-6D4F896D35A5Q38658480-23DB314B-5CFE-4415-A82A-72D5DC201864Q38967211-2C13084B-C5FD-4D7D-B727-5938BEB4AA4EQ39021076-12E2365E-A6A9-4937-B627-682FBBAE1E3FQ39172826-EA215109-A9CB-4A18-8EE1-BC826C0A29D9Q39391134-37801462-A214-426B-85EB-FBDB47CBD4E3Q41104118-71F96C93-2AF8-4BDA-8B83-25E5610762BFQ41872366-4605ED90-A7D7-41BD-8121-19282A0F9B9BQ41926681-076121AC-8CF4-4A44-AD1C-7BCC4E4203A9Q41926759-7D1D9E69-F05F-4626-BAE4-5A968C89A5F9Q41927491-C714E62E-8919-45B7-9904-7A5CB2E7249D
P2860
Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Rates and predictors of hydrox ...... systemic lupus erythematosus.
@en
type
label
Rates and predictors of hydrox ...... systemic lupus erythematosus.
@en
prefLabel
Rates and predictors of hydrox ...... systemic lupus erythematosus.
@en
P2860
P356
P1476
Rates and predictors of hydrox ...... systemic lupus erythematosus.
@en
P2093
Michael F Marmor
P2860
P304
P356
10.1002/ACR.20133
P577
2010-06-01T00:00:00Z